Xing Wei

877 total citations
20 papers, 699 citations indexed

About

Xing Wei is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xing Wei has authored 20 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Xing Wei's work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related Molecular Pathways (3 papers). Xing Wei is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related Molecular Pathways (3 papers). Xing Wei collaborates with scholars based in China, United States and Netherlands. Xing Wei's co-authors include Juanjuan Ou, Haifeng Liu, Yubo Fan, Xili Ding, Ganfeng Xie, Gang Zhou, Houjie Liang, Ping Li, Liqing Yu and Hang Shi and has published in prestigious journals such as PLoS ONE, International Journal of Radiation Oncology*Biology*Physics and Cell Reports.

In The Last Decade

Xing Wei

20 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing Wei China 15 298 200 162 148 130 20 699
Zhengang Zha China 20 341 1.1× 129 0.6× 204 1.3× 93 0.6× 209 1.6× 45 968
Benjamin D. Zeitlin United States 17 508 1.7× 140 0.7× 100 0.6× 261 1.8× 139 1.1× 26 1.0k
Mari H. B. Hjelstuen Norway 9 222 0.7× 313 1.6× 121 0.7× 96 0.6× 171 1.3× 10 790
Yutong Wu China 19 507 1.7× 266 1.3× 110 0.7× 118 0.8× 269 2.1× 51 1.0k
Chu Zhang China 19 397 1.3× 223 1.1× 161 1.0× 233 1.6× 209 1.6× 76 1.1k
Huan‐Tian Zhang China 21 481 1.6× 117 0.6× 156 1.0× 131 0.9× 170 1.3× 40 976
Massimiliano Monticone Italy 17 476 1.6× 161 0.8× 79 0.5× 156 1.1× 56 0.4× 34 1.0k
Hyun Ki Kang South Korea 15 276 0.9× 76 0.4× 191 1.2× 88 0.6× 224 1.7× 23 745
Abdullah Alajati Germany 10 366 1.2× 114 0.6× 55 0.3× 168 1.1× 117 0.9× 17 595
Zhongli Gao China 18 371 1.2× 164 0.8× 92 0.6× 84 0.6× 118 0.9× 50 981

Countries citing papers authored by Xing Wei

Since Specialization
Citations

This map shows the geographic impact of Xing Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Wei more than expected).

Fields of papers citing papers by Xing Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Wei. The network helps show where Xing Wei may publish in the future.

Co-authorship network of co-authors of Xing Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Wei. A scholar is included among the top collaborators of Xing Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Wei. Xing Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Yu, et al.. (2024). DMC triggers MDA-MB-231 cells apoptosis via inhibiting protective autophagy and PI3K/AKT/mTOR pathway by enhancing ROS level. Toxicology in Vitro. 97. 105809–105809. 4 indexed citations
2.
Liu, Ping, Yan Zhuang, Bin-Fei Zhang, et al.. (2021). miR-140-3p regulates the osteogenic differentiation ability of bone marrow mesenchymal stem cells by targeting spred2-mediated autophagy. Molecular and Cellular Biochemistry. 476(12). 4277–4285. 10 indexed citations
3.
Ji, Xiang, Xing Wei, Jie Qian, et al.. (2019). 2′,4′-Dihydroxy-6′-methoxy-3′,5′-dimethylchalcone induced apoptosis and G1 cell cycle arrest through PI3K/AKT pathway in BEL-7402/5-FU cells. Food and Chemical Toxicology. 131. 110533–110533. 25 indexed citations
4.
Zhang, Zengliang, Nan Li, Xing Wei, et al.. (2019). GRM4 inhibits the proliferation, migration, and invasion of human osteosarcoma cells through interaction with CBX4. Bioscience Biotechnology and Biochemistry. 84(2). 279–289. 11 indexed citations
5.
Xu, Mengting, Xing Wei, Jie Fang, & Xiao Li. (2019). Combination of SDF-1 and bFGF promotes bone marrow stem cell-mediated periodontal ligament regeneration. Bioscience Reports. 39(12). 23 indexed citations
6.
Xiao, Jianbo, et al.. (2018). Chaetominine induces cell cycle arrest in human leukemia K562 and colon cancer SW1116 cells. Oncology Letters. 16(4). 4671–4678. 8 indexed citations
7.
Liu, Wenjun, Kai Qian, Xing Wei, et al.. (2017). miR-27a promotes proliferation, migration, and invasion of colorectal cancer by targeting FAM172A and acts as a diagnostic and prognostic biomarker. Oncology Reports. 37(6). 3554–3564. 27 indexed citations
8.
He, Jianming, et al.. (2015). NPC1L1 knockout protects against colitis-associated tumorigenesis in mice. BMC Cancer. 15(1). 189–189. 41 indexed citations
9.
Ding, Xili, Xing Wei, Yan Huang, et al.. (2015). Delivery of demineralized bone matrix powder using a salt-leached silk fibroin carrier for bone regeneration. Journal of Materials Chemistry B. 3(16). 3177–3188. 25 indexed citations
10.
Liao, Xing‐Hua, Yanqi Li, Xing Wei, et al.. (2014). Re-expression and epigenetic modification of maspin induced apoptosis in MCF-7 cells mediated by myocardin. Cellular Signalling. 26(6). 1335–1346. 20 indexed citations
11.
Ou, Juanjuan, Xing Wei, Peng Yuan, et al.. (2014). Neuropilin-2 mediates lymphangiogenesis of colorectal carcinoma via a VEGFC/VEGFR3 independent signaling. Cancer Letters. 358(2). 200–209. 49 indexed citations
12.
Ou, Juanjuan, Hongming Miao, Yinyan Ma, et al.. (2014). Loss of Abhd5 Promotes Colorectal Tumor Development and Progression by Inducing Aerobic Glycolysis and Epithelial-Mesenchymal Transition. Cell Reports. 9(5). 1798–1811. 93 indexed citations
13.
Liu, Haifeng, Xing Wei, Xili Ding, et al.. (2014). Comparison of cellular responses of mesenchymal stem cells derived from bone marrow and synovium on combined silk scaffolds. Journal of Biomedical Materials Research Part A. 103(1). 115–125. 17 indexed citations
14.
Ou, Juanjuan, Jia Deng, Xing Wei, et al.. (2013). Fibronectin extra domain A (EDA) sustains CD133+/CD44+ subpopulation of colorectal cancer cells. Stem Cell Research. 11(2). 820–833. 51 indexed citations
15.
Hong, Shanjuan, Bingyi Shi, Jesper Kers, et al.. (2013). CD4+CD25−Nrp1+ T Cells Synergize with Rapamycin to Prevent Murine Cardiac Allorejection in Immunocompetent Recipients. PLoS ONE. 8(4). e61151–e61151. 11 indexed citations
16.
Liu, Haifeng, Xili Ding, Gang Zhou, et al.. (2013). Electrospinning of Nanofibers for Tissue Engineering Applications. Journal of Nanomaterials. 2013(1). 153 indexed citations
17.
Wang, Ning, et al.. (2012). Interleukin-12 inhibits the survival of human colon cancer stem cells in vitro and their tumor initiating capacity in mice. Cancer Letters. 322(1). 92–97. 22 indexed citations
18.
Xiang, Lisha, Ganfeng Xie, Juanjuan Ou, et al.. (2012). The Extra Domain A of Fibronectin Increases VEGF-C Expression in Colorectal Carcinoma Involving the PI3K/AKT Signaling Pathway. PLoS ONE. 7(4). e35378–e35378. 48 indexed citations
19.
Zhang, Weidong, et al.. (2012). The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression. Molecular Biology. 46(4). 557–562. 38 indexed citations
20.
Ou, Juanjuan, Feng Pan, Peiliang Geng, et al.. (2011). Silencing Fibronectin Extra Domain A Enhances Radiosensitivity in Nasopharyngeal Carcinomas Involving an FAK/Akt/JNK Pathway. International Journal of Radiation Oncology*Biology*Physics. 82(4). e685–e691. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengang Zha Breakdown of academic impact, for papers by Benjamin D. Zeitlin Breakdown of academic impact, for papers by Mari H. B. Hjelstuen Breakdown of academic impact, for papers by Yutong Wu Breakdown of academic impact, for papers by Chu Zhang Breakdown of academic impact, for papers by Huan‐Tian Zhang Breakdown of academic impact, for papers by Massimiliano Monticone Breakdown of academic impact, for papers by Hyun Ki Kang Breakdown of academic impact, for papers by Abdullah Alajati Breakdown of academic impact, for papers by Zhongli Gao
Rankless by CCL
2026